Literature DB >> 26334556

Impact of the Consolidated Standards of Reporting Trials (CONSORT) checklist on reporting of randomized clinical trials in traditional Chinese medicine.

Xue-Ting Liu, Xin Zhang, Shu Wen1, Le Peng1, Qi Hong1, Deying Kang1.   

Abstract

OBJECTIVE: To examine the reporting characteristics and key methodological factors of randomized controlled trials (RCTs) in the field of traditional Chinese medicine and assess whether use of the Consolidated Standards of Reporting Trials (CONSORT) statement is associated with improvement in the quality of reports of RCTs.
METHOD: RCTs published in two major traditional Chinese medicine journals were retrieved and were systematically reviewed. Of those journals, one adopted the CONSORT statement (Journal of Chinese Integrative Medicine (JCIM)) and one did not (Chinese Journal of Integrative Medicine (CJIM)). Items within the CONSORT 2001 and the CONSORT 2010 statements were taken to develop a 63-item coding manual. The Jadad scale was also used to assess methodological quality of RCTs. Two observers assessed the reporting of reports and extracted data independently. P < 0.05 was considered statistically significant. SPSS was used for all analyses.
RESULTS: A total of 76 RCTs were included for the analysis (38 from JCIM and 38 from CJIM). Significant improvements both in the overall quality of reporting (CONSORT score) and reporting of methodological items (Jadad scale) over time were observed in adopter journal (JCIM) (P = 0.001). Overall CONSORT score of studies published during 2010 to 2011 (post-CONSORT) increased 15.30 averagely with 95%CI 8.34 to 22.26 (P = 0.001). Of those, items addressed on reporting of methodological quality were different significantly too. JCIM had more 1.30 items addressed than CJIM in average (95% CI 0.52 to 2.08, P = 0.003). In the multivariate analysis regression, the page length and CONSORT-promoting status have statistically significant associated with the (P = 0.001 and P = 0.040, respectively).
CONCLUSION: Although a large room needs to improve the reporting of randomized clinical trials in traditional Chinese medicine, the impact for improvement of reporting of TCM RCTs has been proven in some extent.
© 2015 Chinese Cochrane Center, West China Hospital of Sichuan University and Wiley Publishing Asia Pty Ltd.

Keywords:  Consolidated Standards of Reporting Trials (CONSORT); quality of reporting; randomized controlled trial (RCT); traditional Chinese medicine (TCM)

Mesh:

Year:  2015        PMID: 26334556     DOI: 10.1111/jebm.12173

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  5 in total

1.  Reporting Quality of Randomized Controlled Trials for the Treatment of Eczema with Chinese Patent Medicine Based on the CONSORT-CHM Formulas 2017.

Authors:  Ming Li; Boyang Zhou; Lihong Zhou; Linfeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-14       Impact factor: 2.629

Review 2.  Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? - A systematic review of reviews: an update.

Authors:  Yanling Jin; Nitika Sanger; Ieta Shams; Candice Luo; Hamnah Shahid; Guowei Li; Meha Bhatt; Laura Zielinski; Bianca Bantoto; Mei Wang; Luciana Pf Abbade; Ikunna Nwosu; Alvin Leenus; Lawrence Mbuagbaw; Muhammad Maaz; Yaping Chang; Guangwen Sun; Mitchell Ah Levine; Jonathan D Adachi; Lehana Thabane; Zainab Samaan
Journal:  J Multidiscip Healthc       Date:  2018-09-27

3.  The quality of reporting in randomized controlled trials of acupuncture for knee osteoarthritis: A cross-sectional survey.

Authors:  Pengli Jia; Li Tang; Jiajie Yu; Jiali Liu; Deying Kang; Xin Sun
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

4.  Quality of randomized controlled trials of new generation antidepressants and antipsychotics identified in the China National Knowledge Infrastructure (CNKI): a literature and telephone interview study.

Authors:  Zheng Tong; Fangzhou Li; Yusuke Ogawa; Norio Watanabe; Toshi A Furukawa
Journal:  BMC Med Res Methodol       Date:  2018-09-24       Impact factor: 4.615

5.  Developing Placebos for Clinical Research in Traditional Chinese Medicine: Assessing Organoleptic Properties of Three Dosage Forms (Oral Liquid, Capsule and Granule).

Authors:  Mengli Xiao; Jiake Ying; Yang Zhao; Qingna Li; Yingpan Zhao; Rui Gao; Fang Lu
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.